An Efficacy and Safety Study of Fremanezumab in Adults With Migraine

- Migraine Prophylaxis
- Completed

Study Title: An Efficacy and Safety Study of Fremanezumab in Adults With Migraine

Teva Identifier: TV48125-CNS-30068 | 2017-002441-30

ClinicalTrials.gov Identifier: NCT03308968

Study Status: Completed

Trial Condition(s): Migraine Prophylaxis

Interventions: Drug: Fremanezumab | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 70 Years

Trial Duration: October 13, 2017 - May 29, 2019

Phase: Phase 3

Study Type

Interventional